Brain and Spine (Jan 2023)
Towards Clinical AKT Inhibition in Glioblastoma
- Hanah Gull,
- Sarah Ertmer,
- Sarah Langer,
- Sied Kebir,
- Jörn Weisner,
- Sven Brandherm,
- Laurèl Rauschenbach,
- Ulrich Sure,
- Daniel Rauh,
- Martin Glas,
- Björn Scheffler
Affiliations
- Hanah Gull
- Department of Neurosurgery And Spine Surgery, University Hospital Essen, Essen, Germany; DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany
- Sarah Ertmer
- DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany
- Sarah Langer
- DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany
- Sied Kebir
- DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany; Division Clinical Neurooncology, Department of Neurology at the University Hospital Essen, Essen, Germany
- Jörn Weisner
- Department of Chemistry and Chemical Biology, TU Dortmund University and Drug Discovery Hub Dortmund (DDHD), Dortmund, Germany
- Sven Brandherm
- Department of Chemistry and Chemical Biology, TU Dortmund University and Drug Discovery Hub Dortmund (DDHD), Dortmund, Germany
- Laurèl Rauschenbach
- Department of Neurosurgery And Spine Surgery, University Hospital Essen, Essen, Germany; DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany
- Ulrich Sure
- Department of Neurosurgery And Spine Surgery, University Hospital Essen, Essen, Germany; DKTK Partner site, University Hospital Essen, Essen, Germany
- Daniel Rauh
- Department of Chemistry and Chemical Biology, TU Dortmund University and Drug Discovery Hub Dortmund (DDHD), Dortmund, Germany
- Martin Glas
- DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany; Division Clinical Neurooncology, Department of Neurology at the University Hospital Essen, Essen, Germany
- Björn Scheffler
- DKTK Partner site, University Hospital Essen, Essen, Germany; DKFZ Division Translational Neurooncology at the West German Cancer Center, Essen, Germany
- Journal volume & issue
-
Vol. 3
p. 102153
